Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About APOP

Cellect Biotechnology is traded on both the NASDAQ and Tel Aviv Stock Exchange (NASDAQ:APOP) (NASDAQ:APOPW) (TASE:APOP). The Company is developing an innovative technology which enables the functional selection of stem cells based on their sensitivity to apoptosis. This functional-based selection is a breakthrough technology in the ability to isolate stem cells from any given tissue, and may improve a variety of stem cells applications. The Companys first planned product line is expected to include unique containers for cell selection in an apoptosis-inducing microenvironment. Cellects first planned commercial product candidate is a medical kit designed for the bone marrow transplantations market, as well as other markets which require cell selection. The Company plans that in the future its technology will be integrated in many production procedures of stem cell-based products.
Primary Exchange: NASDAQ

Wait, Before You Leave...